method graph-linked unified embedding
This reflected an increased percentage of CDH1–TWIST1+ cells and a (GLUE)46, we integrated the two modalities by constructing metacells
decrease of CDH1+TWIST1– cells but no change in proliferation com- containing both transcriptome and chromatin accessibility informapared to controls (Fig. 3k and Extended Data Fig. 6i,j), suggesting that tion, defining a total of 24 clusters from 35,499 metacells (Fig. 4a and
the thickening of the epicardial layer was caused by excessive epicardial Supplementary Table 3). To follow cell trajectories over time, we used
EMT (leading to partial loss of the mesothelial layer) rather than hyper- CellRank47 to infer the terminal macrostates (myocytic, epicardial,
proliferation. The inverted orientation of cells additionally pointed to endothelial and endodermal) and the probability of each cell to transia defect in cell migration, a process that is regulated by NRP2 signaling tion toward these states based on both pseudotime and RNA velocity
in tumor cells of several cancer types42. Of note, immunodetection of information (Fig. 4b and Extended Data Fig. 7a). Along the myocytic
the NRP2 blocking antibody after treatment indicated its predominant trajectory, we detected the early induction of cardiac mesoderm
localization in the epicardial layer, suggesting that it did not reach the (MESP1, PDGFRA and BMP4; days 2 and 3) followed by the emergence
myocardium (Extended Data Fig. 6k). of cells expressing markers of FHF progenitors (TBX5, NKX2.5 and
 SFRP5; days 4 and 5; Fig. 4b and Extended Data Fig. 7a–c). Of note, cells
Epicardioids arise from first heart field (FHF) and juxtacardiac coexpressing markers of anterior second heart field (SHF) precursors
field ( JCF) progenitors (ISL1, TBX1, FGF8 and FGF10), which generate the right ventricle and the
Animal models have shown that the epicardium is formed by cells of outflow tract, were virtually absent (Extended Data Fig. 7d). Differentithe proepicardium, a transient structure located at the venous pole of ated ventricular CMs were detected from day 7 and showed upregulathe looping-stage heart, but the ontogeny of proepicardial precursors tion of the mature ventricular marker MYL2 by day 15 (Extended Data
is still unclear, and even less is known about their human counterparts. Fig. 7b). Epicardial cells and their derivatives first emerged on day
Building on earlier work of Lescroart et al., who first uncovered a devel- 10 and expanded on day 15 (cluster 17; Extended Data Fig. 7b). Strikopmental relationship between the myocardium and the epicardium ingly, the epicardial trajectory included cells that closely matched
at gastrulation43, two studies have recently identified a common pro- the transcriptional signature of the JCF (HAND1, MAB21L2, HOXB6,
genitor pool of the two lineages located at the rostral border of the HOXB5 and BNC2), mainly present at days 7 and 10 (cluster 14; Fig. 4b,c
cardiac crescent in the mouse44,45. Tyser et al. coined the term JCF and and Extended Data Fig. 7a,b,e). These cells were preceded by putative
showed that JCF cells characterized by Mab21l2 expression give rise to ‘pre-JCF’ precursors (cluster 12), which appeared on days 4 and 5 at
both epicardial cells and CMs44. In parallel, Zhang et al. identified an the same time as classical FHF cells (Fig. 4a and Extended Data Fig. 7a).
equivalent Hand1+ progenitor population and confirmed by clonal line- Of note, pre-JCF cells expressed the multipotent cardiovascular
age tracing that at least some of these cells are bipotent for epicardium progenitor marker ISL1 but not the myocytic marker NKX2.5 (ref. 48;


Fig. 5 | Lineage tracing and multiomic analyses support the trilineage c, UMAP plot showing metacell subclusters of the epicardial lineage at day 15; cell
potential of mesothelial epicardial cells in epicardioids. a, Schematic of the types are annotated. d, Violin plots showing the expression levels of markers of
experimental protocol used for lineage tracing of mesothelial epicardial cells. CMs (TNNT2), fibroblasts (TNC) and mural cells (vascular SMCs and pericytes;
Epicardioids differentiated from AAVS1-FRT-flanked STOP-mKate2-HA reporter RGS5) in the epicardial subclusters presented in c. e, UMAP plot showing the
hiPSCs were transduced with a lentiviral vector encoding FLP under the control macrostates inferred in the epicardial subclustering by CellRank; the most
of the CDH1 promoter at day 15 before analysis at day 24. b, Representative advanced differentiation states are annotated. f, UMAP plots (top) and violin
images of immunostaining for the HA tag, the CM marker cTnT and the plots (bottom) showing the transition probabilities of cells for the fibroblast, CM
mesenchymal marker vimentin (top) or the HA tag, vimentin and the SMC marker and mural states inferred by CellRank. g, Left, partition-based graph abstraction
calponin (CNN1; bottom) in infected organoids at day 24; n = 26 epicardioids of the paths taken by cells within the epicardial subclustering. Right, heat maps
analyzed (3 to 4 sections each) from 5 independent differentiations, of which showing the relative gene activity of fibroblast (VIM, TNC, FN1 and COL1A2), CM
22 contained labeled CMs; scale bars, 50 µm. Insets show exemplary labeled CMs, (TNNT2, TTN, ACTN2 and MYH7) and mural (RGS5, KCNJ8, ACTA2 and CSPG4)
SMCs and fibroblasts at higher magnification; scale bars, 10 µm. The inset markers (orange) and the relative gene expression of EMT markers (TWIST1 and
with labeled CMs is shown as a 3D reconstruction in Supplementary Video 3. SNAI2; blue) along the indicated differentiation trajectories.


Nature Biotechnology | Volume 41 | December 2023 | 1787–1800 1794

Article https://doi.org/10.1038/s41587-023-01718-7

Supplementary Fig. 3a). This allowed us to follow their physical segre- was not previously reported in the epicardium (human or otherwise),
gation from ISL1+NKX2.5+ FHF progenitors, which was clearly visible we performed ISL1 immunostaining in human fetal heart tissue to verify
by day 5, with pre-JCF cells already concentrated at the outer layer this finding. This revealed that epicardial cells were indeed positive for
(Supplementary Fig. 3b). ISL1 was still highly expressed in the JCF, ISL1 at 5 weeks after conception, but expression was lost by 6 weeks
followed by a downregulation in the epicardial cluster (Supplemen- (Fig. 4d). We also observed decreased ISL1 expression in epicardial
tary Fig. 3c). This reflected the maintenance of ISL1 in the mesothelial cells of 30-day-old epicardioids, suggesting equivalent expression
epicardium but in very few EPDCs at day 15 (Fig. 4d). As ISL1 expression dynamics (Fig. 4d).


 a b CM

 d24
 CDH1-promoter-FLP


 DNA cTnT
 lentivirus


 VIM HA
 Analysis
 SMC
 d0 d15 d24

 AAVS1-FRT-flanked STOP- d24
 mKate2-HA hiPSCS


 DNA CNN1
 VIM HA
 FB


 c Epicardial subclustering d15

 1 0 2
 d Cardiomyocytes FBs Mural cells
 5 TNNT2 TNC RGS5
 5 3
 7 4
 Expression level


 4 4
 6 3
 3 2
 3 2
 2
 1
 0 Mesothelial epicardium 1 1
 7
 Uncommitted EPDCs 0 0 0
 5
 2 EPDCs (FB diff.) 0 7 5 2 3 4 6 1 0 7 5 2 3 4 6 1 0 7 5 2 3 4 6 1

 3 EPDCs (mural/CM diff.) Epicardial subclusters
 4 EPDCs (CM diff.)
 6 EPDCs (mural diff.) f CM diff. FB diff. Mural diff.
 1 Proliferative cells


 e CellRank
 Transition probabilities


 macrostates 1.0 1.0 1.0


 FB 0 0 0

 1.0 1.0 1.0
 0.8 0.8 0.8
 0.6 0.6 0.6
 0.4 0.4 0.4

 CM 0.2 0.2 0.2
 Mural
 0 0 0
 0 7 5 2 3 4 6 1 0 7 5 2 3 4 6 1 0 7 5 2 3 4 6 1

 Epicardial subclusters

 g CM diff. FB diff. Mural diff.
 Transition probability

 0 7 5 4 0 7 5 2 0 7 3 6
 Graph abstraction Subclusters

 1 VIM
 COL1A2
 FB FN1
 TNC
 TNNT2
 4 0 TTN
 CM ACTN2
 7
 MYH7
 RGS5
 5 ACTA2
 3
 Mural KCNJ8
 2 CSPG4
 6
 Relative gene activity Low High
 TWIST1
 EMT SNAI2
 Relative gene expression Low High


Nature Biotechnology | Volume 41 | December 2023 | 1787–1800 1795

Article https://doi.org/10.1038/s41587-023-01718-7

The human JCF gives rise to both epicardium and myocardium cells, which have important implications for epicardial reactivation as
To functionally validate the fate potential of different progenitor a potential therapeutic target51,52. Specifically, it is still unclear if mampopulations in epicardioids, we generated an hiPSC reporter line in malian epicardial cells can give rise to CMs and whether the lineage fate
which a flippase (FLP) recognition target (FRT)-flanked neomycin cas- of EPDCs is predetermined at the (mesothelial) epicardial stage or if
sette blocking transcription of a pCAG-driven fluorescent reporter specification occurs after EMT22,23,25.
(mKate2) fused to a hemagglutinin (HA) tag was knocked into the To verify the lineage potential of mesothelial epicardial cells in
AAVS1 safe harbor locus49 (Supplementary Results and Supplemen- our system, we generated epicardioids from the FLP/FRT-based hiPSC
tary Fig. 4a–f). For JCF lineage tracing, epicardioids from this reporter reporter line and transduced them with a lentiviral vector encoding FLP
line were transduced with a lentiviral vector encoding an inducible under the control of the CDH1 promoter at day 15 (Fig. 5a and Extended
FLP (FLPERT2) under the control of the MAB21L2 promoter at day 3, and Data Fig. 9a). After 72 h, we detected HA-tag+CDH1+ cells, indicating
4-hydroxytamoxifen (4-OHT) was applied at the beginning of the JCF correct labeling of the mesothelial layer (Extended Data Fig. 9b). On
stage (days 7–8; Fig. 4e and Extended Data Fig. 8a). In the absence day 24, immunofluorescence analysis revealed HA-tag+ SMCs and
of a reliable antibody to MAB21L2, we performed co-staining of the fibroblasts but also CMs (Fig. 5b, Supplementary Video 3 and Extended
HA tag and ISL1 after 48 h to confirm successful labeling of ISL1+ JCF Data Fig. 9c), supporting the fate potentiality previously inferred from
cells located at the outer layer (Extended Data Fig. 8b). On day 12, gene expression (Fig. 1h,i).
immunofluorescence analysis revealed HA-tag+ CMs and epicardial We then exploited our metacell dataset to investigate the timing
cells (both mesothelial and EPDCs), confirming the dual fate potential of epicardial fate decisions. For this, we performed subclustering of
of JCF progenitors as seen in the mouse (Fig. 4f). Having also observed the epicardial lineage at day 15 (differentially expressed genes (DEGs)
MAB21L2+ cells in metacell clusters categorized as FHF progenitors listed in Supplementary Table 6) and analyzed cell trajectories using
(mainly cluster 9), we alternatively applied 4-OHT at the corresponding CellRank. We detected mesothelial cells (subcluster 0), EPDCs undergostage (days 4–5; Extended Data Fig. 8c). In this case, 78.4% of HA-tag+ ing EMT (subclusters 3, 5 and 7) and EPDCs differentiating into fibrocells at day 12 were CMs compared to 54.7% when applying 4-OHT blasts (subcluster 2), mural cells (subcluster 6) or CMs (subcluster 4)
at the JCF stage (Fig. 4f and Extended Data Fig. 8d). Considering the as well as proliferative cells (subcluster 1; Fig. 5c,d and Extended Data
close relationship between the JCF and the FHF in the mouse, it is Fig. 9d). The transition probabilities to each differentiated cell type
unclear whether (some of) these cells descended from classical FHF were balanced among mesothelial cells, suggesting that their fate was
progenitors expressing MAB21L2 or if there exists an early JCF popu- not determined before EMT (Fig. 5e,f). EPDCs in subclusters 7 and 5
lation with higher commitment to the myocytic lineage. Moreover, also appeared to hold trilineage potential, while EPDCs in subcluster
a closer look at fate trajectories in our metacell dataset revealed 3 were committed toward mural and, to a lesser extent, myocytic difheterogeneity in the JCF cluster, with the majority of cells having ferentiation (Fig. 5f). Assessing chromatin accessibility patterns along
a high probability for myocytic differentiation but only a subset epicardial differentiation paths showed that the gene activity for CM,
appearing to be bipotent for the myocytic and epicardial lineages fibroblast and mural lineage markers was highest at the end of each
(Fig. 4g). We inferred the gene regulatory networks (GRNs) associ- respective trajectory, but, importantly, there was also a peak of gene
ated with each fate using Pando50, a recently established algorithm activity for competing lineage markers during and shortly after EMT,
leveraging both transcriptome and chromatin accessibility data suggesting a highly plastic state of EPDCs (Fig. 5g and Extended Data
(Fig. 4h and Supplementary Tables 4 and 5). We identified well- Fig. 9e). Overall, our data do not support the existence of discrete
known transcription factors (TFs) involved in CM differentiation (for subsets of embryonic epicardial cells restricted to a single lineage
example, GATA4, ISL1 and MEIS1) and uncovered putative drivers of before EMT but rather advocate a model of dynamic fate specification
epicardial differentiation of JCF cells (for example, TFAP2B, HAND2 over time.
and FOS; Fig. 4h,i). The expression patterns of positively and negatively
regulated downstream targets of TFs specific of each fate (for example, Epicardioids mimic left ventricular hypertrophy (LVH) and
GATA4 and TFAP2B) clearly indicated distinct regulatory programs fibrosis
reflecting the dual potential of JCF cells (Fig. 4j and Extended Data Both inherited and acquired cardiovascular disorders can manifest
Fig. 8e,f). as LVH, a maladaptive remodeling of the myocardium that increases
 risk for heart failure and life-threatening arrhythmia53,54. Current 2D
Exploring the lineage potential of the human epicardium in vitro models largely recapitulate the myocytic features of LVH but
Beyond their embryonic origin, there are still many open questions fail to account for the pivotal role of fibrosis in the progression toward
concerning the molecular and functional heterogeneity of epicardial heart failure55,56. Hypothesizing that the 3D multilineage architecture of

Fig. 6 | Modeling stress-induced and congenital ventricular hypertrophy amplitude in the OM or IM of treated and control epicardioids; control, n = 130
and fibrosis in epicardioids. a, Expression of hypertrophy markers in ET1- transients per layer and 5 epicardioids; ET1, n = 106 transients per layer and 4
treated epicardioids and controls. Data are shown as mean ± s.e.m.; control, epicardioids. Three independent differentiations per group were performed.
n = 5 epicardioids; ET1, n = 3 epicardioids per concentration. Two independent Data were analyzed by Kruskal–Wallis test with a Dunn’s multiple comparisons
differentiations per group were performed. Data were analyzed by one-way test. h, Percentage of treated and control epicardioids displaying arrhythmic
ANOVA with a Sidak’s multiple comparisons test. b, Top, CMs from day 30 events. Data are shown as mean ± s.e.m.; control, n = 5 epicardioids; ET1, n = 4
treated or control epicardioids stained for cTnT and plakophilin-2 (PKP2); epicardioids. Three independent differentiations per group were performed.
scale bars, 100 µm. Bottom, CM area; n = 260 CMs from 3 differentiations per Data were analyzed by unpaired two-tailed t-test. i, Immunostaining for cTnT,
group. Data were analyzed by unpaired two-tailed t-test. c, Expression of ECM CDH1 and vimentin in epicardioids from day 15 hiPSCs derived from an individual
markers in treated and control epicardioids. Data are shown as mean ± s.e.m.; with Noonan syndrome; scale bars (top), 100 µm; scale bars (bottom), 50 µm.
control, n = 5 epicardioids; ET1, n = 3 epicardioids per concentration and 2 Arrowheads indicate the mesothelial epicardium layer, and arrows indicate
independent differentiations per group. Data were analyzed by one-way ANOVA EPDCs. j, Immunostaining for cTnT and FN1 in control and Noonan syndrome
with a Sidak’s multiple comparisons test. d, Immunostaining for cTnT and FN1 organoids (day 15). Asterisks indicate fibrotic remodeling; scale bars, 100 µm.
in treated and control epicardioids; scale bars, 200 µm. Asterisks indicate k, Immunostaining for cTnT, FN1, α-SMA and COL3 in Noonan syndrome
fibrotic remodeling. e, Immunostaining for cTnT, α-SMA, FN1 and COL3 in epicardioids (day 15); scale bars, 50 µm. Box plots in b and g indicate the median
ET1-treated epicardioids; scale bars, 50 µm. f, Exemplary Fluo-4 traces in and 25th and 75th percentiles, with whiskers extending to the 5th and 95th
treated and control epicardioids. Blue arrows indicate 0.5-Hz pacing, and red percentiles. Images in d, e and i–k are representative of three independent
arrows indicate arrhythmic events; AU, arbitrary units. g, Calcium transient differentiations.


Nature Biotechnology | Volume 41 | December 2023 | 1787–1800 1796

Article https://doi.org/10.1038/s41587-023-01718-7

epicardioids could resolve this gap, we treated 1-month-old epicardi- Having successfully recapitulated a stress-induced phenotype, we
oids with endothelin-1 (ET1), a potent vasoconstrictor known to induce next tested the capacity of epicardioids to model congenital myocarhypertrophy in vivo and in vitro57,58. ET1 triggered a dose-dependent dial fibrosis. For this, we used hiPSCs from an individual with Noonan
upregulation of myocytic hypertrophy markers (NPPA, NPPB, ACTA1 syndrome who presented with severe LVH and myocardial fibrosis at
and MYH7/MYH6) and an increase in CM size (Fig. 6a,b). Importantly, birth (Fig. 6i). We recently reported that hiPSC-derived CMs from this
the concomitant upregulation of ECM genes (COL1A2, COL3A1, FN1 individual displayed cell cycle defects, leading to hyperproliferation
and POSTN) suggested the onset of a fibrotic response, which was cor- rather than a classical hypertrophic phenotype when cultured in 2D60.
roborated by abundant ECM deposition in the subepicardial space and The same was observed in individual-specific epicardioids; they did
the emergence of α-smooth muscle actin-positive (α-SMA+) myofibro- not have larger CMs than healthy controls and did not upregulate
blasts (Fig. 6c–e). Calcium imaging in ET1-treated epicardioid slices hypertrophy markers but showed increased CM proliferation across the
additionally revealed CM dysfunction across the myocardial layers, myocardial layers (Supplementary Fig. 5a–c). We additionally observed
including frequent arrhythmic events and decreased calcium transient an upregulation of ECM genes and the appearance of areas containamplitudes, two well-established features of failing hearts59 (Fig. 6f–h). ing large numbers of fibroblasts and SMA+ myofibroblasts as early as


 a NPPA NPPB ACTA1 MYH7/MYH6 b
 0.0001 Control ET1 50 nM
 0.0005 0.0221
 relative to GAPDH
 mRNA expression


 0.0018


 DNA cTnT PKP2
 0.0162
 0.0002 0.0151 Control
 0.0118
 0.5 0.4 0.0122 0.20 0.8 ET1 25 nM
 0.4 0.3 0.15 0.6
 0.3 ET1 50 nM
 0.2 0.10 0.4
 0.2
 0.1 0.1 0.05 0.2
 0 0 0 0
 15,000 <0.0001


 CM area (µm2)
 c COL1A2 COL3A1 FN1 POSTN 10,000
 relative to GAPDH
 mRNA expression


 0.0001 0.0011 0.0103 5,000
 0.0044
 0.0007 0.0388
 Control
 1.5 1.0 0.0152 0.8 0.10
 ET1 25 nM 0
 0.8 0.6 l
 1.0 0.6 ET1 50 nM tro nM
 0.4 0.05 n 0
 0.5 0.4
 0.2 Co T1
 5
 0.2 E
 0 0 0 0


 d Control ET1 50 nM
 e
 DNA cTnT VIM FN1 DNA cTnT VIM α-SMA DNA cTnT VIM COL3
 d36 d36 d36 d36 d36
 cTnT


 ET1 50 nM
 Fibronectin


 *
 *
 *
 VIM FN1 VIM α-SMA VIM COL3


 f g h
 Control IM OM
 Percentage of epicardioids


 Control ET1 50 nM ET1 50 nM
 with arrhythmic events


 0.0015
 fluorescence (AU)


 1.4 1.4 0.5 Hz
 1.3 1.3 1.5 <0.0001 100
 Amplitude (AU)


 80
 Fluo-4


 1.2 1.2 Arrhythmic <0.0001
 1.1 1.1 1.0 60
 event 40
 1.0 1.0
 0.9 0.9 0.5 20
 0 2 4 6 8 10 0 2 4 6 8 10 0
 0 l
 Time (s) IM OM ro nM
 o nt 50
 C T1
 E
 i Noonan syndrome j k
 PTPN11N308S/+ DNA cTnT FN1
 d15 d15 DNA cTnT VIM FN1 DNA cTnT VIM α-SMA DNA cTnT VIM COL3
 d15 d15 d15
 Control


 Noonan syndrome
 DNA cTnT CDH1 VIM


 Noonan syndrome


 d15
 *

 * * VIM FN1 VIM α-SMA VIM COL3


Nature Biotechnology | Volume 41 | December 2023 | 1787–1800 1797

Article https://doi.org/10.1038/s41587-023-01718-7

day 15, indicating that the cellular environment of epicardioids is and competing interests; and statements of data and code availability
indeed permissive to fibrotic changes associated with developmental are available at https://doi.org/10.1038/s41587-023-01718-7.
defects (Fig. 6j,k and Supplementary Fig. 5d).
